Sifted shines a spotlight on the university-affiliated venture funds supporting spinouts, with 92% of the UK’s Russell Group universities now having an affiliated venture fund. @AlbionVC @UCL_Business @Siftedeu Read more: https://t.co/MFe7DjNtYn

Today is #WorldCancerDay# – At UCLB we are so proud of the work our spinouts do to bring hope to millions 👏 Fighting cancer is among medicine’s biggest challenges, and several UCLB spinouts are rising to meet that challenge by bringing to market groundbreaking treatments and diagnostic technologies born out of @ucl research. 📖Read more about the impact these spinouts have in the fight against cancer: https://t.co/F15LzUX7gh

In 2024 the Spinout Review anniversary has shown further commitment to nurturing university research and innovation. Spinouts represent the bridge between groundbreaking research and real-world impact, generating jobs, driving economic growth, and transforming lives. The Spinout Review has been a landmark moment for the entire tech transfer industry, kicking off a step-change in better deal-making, proliferation of tech transfer clusters and the hardwiring of spinout growth into the UK's industrial strategy. Find out more about the spinout review here: https://t.co/ZO0QIJi9pu

Earlier this year, @UCL spinout company Autolus Therapeutics announced that the U.S. Food and Drug Administration (FDA) had granted marketing approval for AUCATZYL® (obecabtagene autoleucel, obe-cel), for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). UCLB has supported Autolus in protecting and licensing the obe-cel technology, enabling it to attract further capital to fund its development. More here: https://t.co/ZXqNNcT9e4 #BioPharm# #TechTransfer# #Spinouts#

Get to know more about UCL spinout @odin_vision, a company developing #AI# software to improve endoscopic procedures for better early detection and diagnosis of cancer. We recently chatted to Professor @DanStoyanov , Scientific Advisor at Odin, to learn about his experiences of taking his research to market, the impact that the spinout is making, and his advice for aspiring entrepreneurs. On #WorldCancerDay#, learn about Professor Stoyanov's commercialisation journey: https://t.co/9nd3w5k9rZ @UCLEnterprise | @uclcs

The @FinancialTimes has run a piece highlighting UCLB spinout Autolus Therapeutics’ journey to produce therapies for cancer side effects 👏 The news story focuses on the work taking place at Autolus’ Stevenage facility, which is manufacturing the latest generation of an innovative, personalised cancer treatment: a new Car-T cell therapy to treat the blood cancer acute lymphoblastic leukaemia. 📖 Read more here: https://t.co/3IBqRtuZsL

Thanks to those who joined us yesterday for another great I/O Lab Coffee Club session with co-founders of UCL spinout Oriole Networks, Professor George Zervas and James Regan. We look forward to seeing you at the next Coffee Club event 👏 @ucl | @UCLTF | @UCLEngineering | @ucleeenews | @UCLEnterprise

A great end to the year for the EnAcuity team. The UCLB and @imperialcollege spinout has secured £1.28 million pre-seed funding in a round led by Twin Path Ventures, joined by the London Co-Investment Fund and Crista Galli Ventures. The team are looking to further build and apply EnAcuity’s product, which is the first-ever software-only clinical solution for hyperspectral imaging. @WEISS_UCL @uclcs #MedTech# #MedicalImaging# More here: https://t.co/puUCTTpHfz

It’s been an unforgettable year for Oriole Networks, with the UCLB spinout securing $13m in seed funding to accelerate development of its ‘all-optical’ infrastructure, enabling Large Language Models (LLMs) to be trained up to a hundred times faster with AI inference significantly accelerated, for a fraction of the network power. Later this year, Oriole raised an additional $22m, taking the total raised this year to $35m. By 2025, it plans to have its early-stage products in the hands of customers, creating an ecosystem of photonic networking for AI. Read more: https://t.co/dYj27BEsJQ

Last chance to sign up for tomorrow's I/O Lab Coffee Club event. Join us in conversation with Professor George Zervas (@ucleeenews) and James Regan, co-founders of @ucl spinout Oriole Networks. More here ⬇️

🔊 Calling UCL academics! Don't miss our next I/O Lab Coffee Club session with Professor George Zervas (UCL's Department of Electronic and Electrical Engineering) and James Regan, co-founders of @ucl spinout Oriole Networks. Discover more and sign up here: https://t.co/ersYMn6UAi